{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:43:57Z","timestamp":1793321037465,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017599","name":"Science and Technology Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2018C37132"],"award-info":[{"award-number":["2018C37132"]}],"id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis, a rare subtype of autoimmune encephalitis, was first reported by Lai et\u00a0al. The AMPAR antibodies target against extracellular epitopes of the GluA1 or GluA2 subunits of the receptor. AMPARs are expressed throughout the central nervous system, especially in the hippocampus and other limbic regions. Anti-AMPAR encephalitis was more common in middle-aged women and most patients had an acute or subacute onset. Limbic encephalitis, a classic syndrome of anti-AMPAR encephalitis, was clinically characterized by a subacute disturbance of short-term memory loss, confusion, abnormal behavior and seizure. Magnetic resonance imaging often showed T2\/fluid-attenuated inversion-recovery hyperintensities in the bilateral medial temporal lobe. For suspected patients, paired serum and cerebrospinal fluid (CSF) testing with cell-based assay were recommended. CSF specimen was preferred given its higher sensitivity. Most patients with anti-AMPAR encephalitis were complicated with tumors, such as thymoma, small cell lung cancer, breast cancer, and ovarian cancer. First-line treatments included high-dose steroids, intravenous immunoglobulin and plasma exchange. Second-line treatments, including rituximab and cyclophosphamide, can be initiated in patients who were non-reactive to first-line treatment. Most patients with anti-AMPAR encephalitis showed a partial neurologic response to immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2021.652820","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T01:56:20Z","timestamp":1621562180000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Tian-Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Lun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit458","article-title":"Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A Clinical Approach to Diagnosis of Autoimmune Encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix319","article-title":"Epidemiology of Meningitis and Encephalitis in the United States, 2011-2014","volume":"65","author":"Hasbun","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa254","article-title":"Neural Antibody Testing in Patients With Suspected Autoimmune Encephalitis","author":"Budhram","year":"2020","journal-title":"Clin Chem"},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/14728222.2021.1856370","article-title":"Autoimmune Encephalitis: Novel Therapeutic Targets at the Preclinical Level","volume":"25","author":"Sell","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21589","article-title":"AMPA Receptor Antibodies in Limbic Encephalitis Alter Synaptic Receptor Location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cb3e52","article-title":"Reversible Paraneoplastic Limbic Encephalitis Associated With Antibodies to the AMPA Receptor","volume":"74","author":"Bataller","year":"2010","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d3e404","article-title":"The Expanding Clinical Profile of anti-AMPA Receptor Encephalitis","volume":"74","author":"Graus","year":"2010","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.05.011","article-title":"Rapid Progression and Brain Atrophy in anti-AMPA Receptor Encephalitis","volume":"261","author":"Wei","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2014.04.002","article-title":"Serial Brain (1)(8)FDG-PET in anti-AMPA Receptor Limbic Encephalitis","volume":"271","author":"Spatola","year":"2014","journal-title":"J Neuroimmunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1715","article-title":"Clinical Spectrum of Encephalitis Associated With Antibodies Against the Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature","volume":"72","author":"Joubert","year":"2015","journal-title":"JAMA Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.02.011","article-title":"Anti-AMPA Receptor Encephalitis Associated With Thymomatous Myasthenia Gravis","volume":"281","author":"Li","year":"2015","journal-title":"J Neuroimmunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA Receptor Antibodies: Novel Findings in a Case Series of 22 Patients","volume":"84","author":"Hoftberger","year":"2015","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1212\/NXI.0000000000000118","article-title":"Posterior Cortical and White Matter Changes on MRI in Anti-AMPA Receptor Antibody Encephalitis","volume":"2","author":"Elamin","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308814","article-title":"Limbic Encephalitis Due to GABAB and AMPA Receptor Antibodies: A Case Series","volume":"86","author":"Dogan Onugoren","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/273192","article-title":"Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman With Turner Syndrome","volume":"2015","author":"Quaranta","year":"2015","journal-title":"Case Rep Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3263718","article-title":"Small-Cell Lung Cancer With Positive Anti-NMDAR and Anti-AMPAR Antibodies Paraneoplastic Limbic Encephalitis","volume":"2016","author":"Boangher","year":"2016","journal-title":"Case Rep Neurol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-016-2680-0","article-title":"Rapidly Progressive Neurological Deterioration in anti-AMPA Receptor Encephalitis With Additional CRMP5 Antibodies","volume":"37","author":"Yang","year":"2016","journal-title":"Neurol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12883-017-0823-4","article-title":"Hashimoto\u2019s Encephalitis Associated With AMPAR2 Antibodies: A Case Report","volume":"17","author":"Zhu","year":"2017","journal-title":"BMC Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001304","article-title":"An Uncommon Presentation of a Primary Bone Tumor: Anti-AMPA (Anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid) Receptor Limbic\/Paraneoplastic Encephalitis as a Presenting Feature of Ewing Sarcoma","volume":"40","author":"Koh","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9682-17","article-title":"Clinical Relapse of Anti-AMPAR Encephalitis Associated With Recurrence of Thymoma","volume":"57","author":"Omi","year":"2018","journal-title":"Intern Med"},{"key":"B22","article-title":"Limbic Encephalitis Associated With Antibodies Against the alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: A Case Report","volume":"39","author":"Zhu","year":"2018","journal-title":"Neuro Endocrinol Lett"},{"key":"B23","doi-asserted-by":"publisher","first-page":"bcr2018225745","DOI":"10.1136\/bcr-2018-225745","article-title":"Anti-AMPA Receptor Encephalitis Associated With Medullary Thyroid Cancer","volume":"2018","author":"Samad","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9153-8","article-title":"Patient Characteristics and Outcome Associations in AMPA Receptor Encephalitis","volume":"266","author":"Laurido-Soto","year":"2019","journal-title":"J Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e227893","DOI":"10.1136\/bcr-2018-227893","article-title":"Fulminant Thymomatous AMPAR-antibody Limbic Encephalitis With Hypertonic Coma, Bruxism, an Isoelectric Electroencephalogram and Temporal Cortical Atrophy, With Recovery","volume":"12","author":"Urriola","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7326\/L18-0593","article-title":"Autoimmune Encephalitis Secondary to Melanoma","volume":"170","author":"Daneshmand","year":"2019","journal-title":"Ann Intern Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12883-019-1358-7","article-title":"Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor GluR2 Encephalitis in a Myasthenia Gravis Patient With Complete Thymectomy: A Case Report","volume":"19","author":"Luo","year":"2019","journal-title":"BMC Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e01528","DOI":"10.1002\/brb3.1528","article-title":"Limbic Encephalitis Associated With AMPA Receptor and CRMP5 Antibodies: A Case Report and Literature Review","volume":"10","author":"Jia","year":"2020","journal-title":"Brain Behav"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e01540","DOI":"10.1002\/brb3.1540","article-title":"Different FDG-PET Metabolic Patterns of anti-AMPAR and anti-NMDAR Encephalitis: Case Report and Literature Review","volume":"10","author":"Wei","year":"2020","journal-title":"Brain Behav"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/1941874419880423","article-title":"Recurrent Thymoma-Associated Paraneoplastic Encephalitis Resulting From Multiple Antibodies: A Case Report","volume":"10","author":"Safadi","year":"2021","journal-title":"Neurohospitalist"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04900-w","article-title":"Long-Term Follow-Up of a Child With anti-AMPA Receptor Encephalitis","volume":"42","author":"Qiao","year":"2021","journal-title":"Neurol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.04.009","article-title":"Structural and Functional Architecture of AMPA-Type Glutamate Receptors and Their Auxiliary Proteins","volume":"94","author":"Greger","year":"2017","journal-title":"Neuron"},{"key":"B33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human Autoantibodies Against the AMPA Receptor Subunit GluA2 Induce Receptor Reorganization and Memory Dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate Receptor Ion Channels: Structure, Regulation, and Function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-006-0275-4","article-title":"Role of AMPA Receptors in Synaptic Plasticity","volume":"326","author":"Sprengel","year":"2006","journal-title":"Cell Tissue Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24293","article-title":"Cellular Plasticity Induced by anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Encephalitis Antibodies","volume":"77","author":"Peng","year":"2015","journal-title":"Ann Neurol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05299-y","article-title":"Brain (18)F-FDG PET for the Diagnosis of Autoimmune Encephalitis: A Systematic Review and a Meta-Analysis","author":"Bordonne","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.184333","article-title":"Diagnostic Value of (18)F-FDG PET\/CT Versus MRI in the Setting of Antibody-Specific Autoimmune Encephalitis","volume":"58","author":"Solnes","year":"2017","journal-title":"J Nucl Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.03.026","article-title":"Magnetic Resonance Imaging and Positron Emission Tomography in anti-NMDA Receptor Encephalitis: A Systematic Review","volume":"52","author":"Bacchi","year":"2018","journal-title":"J Clin Neurosci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42466-019-0048-7","article-title":"SOP: Antibody-Associated Autoimmune Encephalitis","volume":"2","author":"Rossling","year":"2020","journal-title":"Neurol Res Pract"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/wps.20001","article-title":"Secondary Psychoses: An Update","volume":"12","author":"Keshavan","year":"2013","journal-title":"World Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-020-01113-2","article-title":"Autoimmune Encephalitis as a Differential Diagnosis of Schizophreniform Psychosis: Clinical Symptomatology, Pathophysiology, Diagnostic Approach, and Therapeutic Considerations","volume":"270","author":"Endres","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3345\/kjp.2019.00598","article-title":"Autoimmune Encephalitis and Epilepsy: Evolving Definition and Clinical Spectrum","volume":"63","author":"Seo","year":"2020","journal-title":"Clin Exp Pediatr"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and Prognostic Factors for Long-Term Outcome in Patients With anti-NMDA Receptor Encephalitis: An Observational Cohort Study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1708714","article-title":"Acute Viral Encephalitis","volume":"379","author":"Tyler","year":"2018","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune Encephalitis: Proposed Best Practice Recommendations for Diagnosis and Acute Management","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2015.1115720","article-title":"Immune Therapy in Autoimmune Encephalitis: A Systematic Review","volume":"15","author":"Nosadini","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and Antibodies to Synaptic and Neuronal Cell Surface Proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal Autoantigens\u2013Pathogenesis, Associated Disorders and Antibody Testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating Autoimmune Encephalitis: A Systematic Review","volume":"96","author":"Broadley","year":"2019","journal-title":"J Autoimmun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1177\/1756285617722347","article-title":"Treatment Strategies for Autoimmune Encephalitis","volume":"11","author":"Shin","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.652820\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T01:56:23Z","timestamp":1621562183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.652820\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2021.652820"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.652820","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"article-number":"652820"}}